On May 28, Amphenol rose 3.03% in regular trading, trading at $143.895/share, with trading volume of $274 million.

On the news front, BNP Paribas raised Amphenol's target price from $195 to $200, maintaining its outperform rating. Simultaneously, UBS identified the stock as a \"sentiment mismatch\" name, suggesting market pricing has diverged from underlying fundamentals. These bullish analyst signals reinforced the stock's ongoing recovery trajectory.

The upgrade comes against the backdrop of strong Q1 results, with quarterly net sales reaching $7.62 billion, up 58.39% year-over-year, and net income of $933 million, representing 26.46% growth. Market concerns over CCS consolidation-related margin dilution — where the integration is expected to contribute approximately $900 million in revenue but only about $0.02 to adjusted EPS — have been progressively digested as the electronic components industry continues its recovery cycle, supporting the stock's rebound momentum.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)